(Q33950435)

30 July 2017

1 reference

title

Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease (English)

1 reference

30 July 2017

0 references

Perry G

1 reference

30 July 2017

Shi J

1 reference

30 July 2017

Smith MA

series ordinal

1 reference

30 July 2017

Friedland RP

series ordinal

1 reference

30 July 2017

publication date

1 March 2000

1 reference

30 July 2017

published in

Neurobiology of Aging

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

357-361

1 reference

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Association of genetic polymorphisms in the ACE, ApoE, and TGF beta genes with early onset ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

A Pilot Microradiological Investigation on the Occurrence of Calcifications in Various Arteries of the Human Body

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

SP-40,40 is a constituent of Alzheimer's amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

The role of APOE polymorphisms in late-onset dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

beta-Amyloid peptides and enhancement of vasoconstriction by endothelin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

The vasoactivity of A beta peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

β‐Amyloid (Aβ1–40)–Evoked Changes in Vascular Reactivity Are Mediated via an Endothelium‐Specific Mechanism: Studies Using Rabbit Isolated Aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Altered glucose metabolism in microvessels from patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Cerebral vessels in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Cerebrovascular Degeneration Is Related to Amyloid‐β Protein Deposition in Alzheimer's Diseasea

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Classification, Diagnosis and Treatment of Vascular Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

The Risk of Dementia among Persons with Diabetes Mellitus: A Population‐Based Cohort Studya

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Thickening of the basement membrane of cortical capillaries in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Distribution of clusterin in Alzheimer brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Cerebrovascular muscle atrophy is a feature of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

ApoE, Alzheimer's Disease, and Recovery from Brain Stressa

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

A population-based study of dementia in 85-year-olds.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

A review on blood pressure and ischaemic white matter lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

The effect of APOE on dementia is not through atherosclerosis: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Apolipoprotein E and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Ultrastructural evidence for the formation of amyloid fibrils within cardiomyocytes in isolated atrial amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Is Alzheimer's disease an apolipoprotein E amyloidosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

Amyloid Angiopathy and Blood–Brain Barrier Changes in Alzheimer's Diseasea,b

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900119-6

7 January 2021

10.1016/S0197-4580(00)00119-6

Identifiers

DOI

1 reference

30 July 2017

1 reference